The intestine plays an important role in host protection and immune system modulation. To detect pathogenic organisms a large number of immune cells circulate through the gastrointestinal tract, but the mechanisms underlying the trafficking of immune cells are still poorly understood. A new class of immunoregulatory cells has been recently identified. These cells express the transcriptional regulator RORyt that regulates expression of key cytokines including IL-17 and IL-22, and is critical for differentiation of lymphoid structures in the intestine. In this application we aim to define the mechanisms regulating the development and trafficking of such cells into the intestinal mucosa. These studies are a logical development of our previous application, and build upon our recently published observations on the role of chemokines in the trafficking of cells into the intestine. In addition, we plan to examine the role of IL-23 in the development and function of RORyt+ cells. Genetic studies in humans indicate an association between increased IL-23 signaling and development of IBD. Furthermore, our own transgenic studies show that systemic expression of IL-23 subunit p19 results in severe inflammation. It remains unclear so far if disturbances in IL-23 signaling in the intestine is sufficient to promote inflammation at to what degree this response depends on RORyt+ cells. To address the role of chemokines and IL-23 in the development, trafficking and function of RORyt+ cells in the intestine we will: 1) define the role of chemokines in the distribution of RORyt+ cells in the intestine;2) define the contribution of IL-23 to the development and function of RORyt+ cells during homeostasis and disease.
In this application we aim to define the mechanisms regulating the development, trafficking and function of a specialized group of cells in the intestine. These cells have been shown to produce cytokines that promote inflammatory bowel disease. Our studies will hopefully identify critical factors controlling the migration and activity of such cells and therefore contribute to the development of new treatments for diseases of the intestine.
|Chen, L; He, Z; Slinger, E et al. (2015) IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology. Mucosal Immunol 8:390-402|
|Kent, Andrew; Blander, J Magarian (2014) Nod-like receptors: key molecular switches in the conundrum of cancer. Front Immunol 5:185|
|Bongers, Gerold; Pacer, Michelle E; Geraldino, Thais H et al. (2014) Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. J Exp Med 211:457-72|
|Sicherer, Scott H; Wood, Robert A; Vickery, Brian P et al. (2014) The natural history of egg allergy in an observational cohort. J Allergy Clin Immunol 133:492-9|
|Caubet, Jean-Christoph; Masilamani, Madhan; Rivers, Neisha A et al. (2014) Potential non-T cells source of interleukin-4 in food allergy. Pediatr Allergy Immunol 25:243-9|
|Moretti, Julien; Blander, J Magarian (2014) Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes. Curr Opin Immunol 26:100-10|
|Blander, J Magarian (2014) A long-awaited merger of the pathways mediating host defence and programmed cell death. Nat Rev Immunol 14:601-18|
|Davenport, Michael; Poles, Jordan; Leung, Jacqueline M et al. (2014) Metabolic alterations to the mucosal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 20:723-31|
|Hammerich, Linda; Bangen, Jörg M; Govaere, Olivier et al. (2014) Chemokine receptor CCR6-dependent accumulation of ?? T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology 59:630-42|
|Manganaro, Lara; Pache, Lars; Herrmann, Tobias et al. (2014) Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-?B-dependent manner. J Virol 88:7528-40|
Showing the most recent 10 out of 50 publications